secwatch.observer — SEC 8-K summary
======================================

Issuer:     NextCure, Inc. (NXTC)
CIK:        0001661059
Form:       8-K
Filed at:   2025-08-25T23:59:59+00:00
Accession:  0001558370-25-011752
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

NextCure CSO resigns effective Sept 1, 2025; no replacement named
-----------------------------------------------------------------

- Solomon Langermann, Ph.D., resigned as Chief Scientific Officer, effective September 1, 2025.
- Resignation was not due to any disagreement with the Company or its operations.
- No successor has been announced at this time.
- Board and Company thanked Dr. Langermann for his contributions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661059/000155837025011752/0001558370-25-011752-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661059/000155837025011752/nxtc-20250821x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-011752

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer